Global Gene Therapy Products Market Companies

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Global Gene Therapy Products Market Companies

  • Healthcare
  • Apr 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Companies Covered

Highest Market Share

Dominant Companies

    Other Companies

    Global Gene Therapy Products Market Share Analysis

    Star The data presented is for visualization purposes only and may not reflect actual results.

    Company Overview

    Overview

    The company overview furnishes clients with basic information about the company’s background and core operations. In this section, we generally include details about the company's founding, mission, key milestones, and overarching business activities. In addition, this section aims to give clients insights into the competitor's industry focus, illustrating where they direct their efforts and investments within the market landscape.

    Product Portfolio

    Understanding the competitor's product portfolio helps identify their strengths and weaknesses in various product categories. Our product portfolio section offers a detailed overview of the range of products and services that the companies offer. This includes information on the types of products, product information, and product segment. By analyzing the competitor’s product portfolio, clients can gain insights into their strategic focus areas, innovation capabilities, and market positioning.

    Market Share Geographical Coverage

    Analyzing sales geographical coverage also includes understanding the competitor's market penetration, customer base diversity, and regional sales tactics. To measure the economic occurrences of a competitor through sales, it is essential to analyze their sales distribution across different regions. This involves examining the sales volume, revenue contribution, and growth rates in various geographical markets. This section tells about the regions where the competitor is most successful, which can indicate strong market demand or effective sales strategies.

    Recent Developments

    The competitor's approach to market opportunities and challenges is reflected in their diverse strategic actions. Under this section, you can get an understanding of the competitor's behavior and attitude towards market opportunities and challenges. We got you covered with the latest updates on product launches, expansions, mergers and acquisitions, collaborations, partnerships, agreements, joint ventures, and awards and certifications for various companies.

    Nucleus : Company Analysis Platform

    Frequently Asked Questions

    Companies such as Bristol-Myers Squibb Company (US), GSK plc (UK), Merck KGaA (Germany), Novartis AG (Switzerland) and Danaher Cooperation (US) are the major companies in the Gene Therapy Products market.
    In January 2025, bluebird bio, Inc. received FDA approval for its LentiGlobin gene therapy for sickle cell disease, marking a significant milestone in the treatment of hematologic diseases. The one-time treatment aims to increase healthy hemoglobin production, improving patients' quality of life and potentially reducing the need for lifelong transfusions. In December 2024, Gilead Sciences, Inc. launched a new clinical trial for its Yescarta gene therapy to treat relapsed or refractory B-cell lymphoma. The trial will assess the long-term efficacy and safety of Yescarta in combination with new immune-modifying therapies, further advancing its oncology portfolio and contributing to the ongoing evolution of gene therapies aimed at improving cancer survival rates.
    The countries covered in the gene therapy products market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and rest of Middle East and Africa.